|    editor@medjpps.com

www.medjpps.com

Received date : 18-01-2021 Revised date : 04-02-2021 Accepted date : 05-02-2021 Published date : 31-03-2021

Mediterr J Pharm Pharm Sci 1 (1): 32-35, 2021

DOI: https://doi.org/10.5281/zenodo.5171391

Short Communication


Evaluation of knowledge, attitude and practice of pharmacovigilance among Libyan healthcare professionals

Iman Elmahdi, Hanin F. Hussin, A. Abdullah, Faraj Alamismaery, Elzahra S. Buzariba, Amna R. Bograin and Aisha A. Kshbor


Abstract

The aim of this study was to evaluate the knowledge, attitude, and practice of pharmacovigilance by healthcare professionals in Benghazi. A structured questionnaire adapted from a previous validated study. One hundred questionnaires were distributed in August 2019 and filled by healthcare providers working at different hospitals in Benghazi, Libya. Participants were 57% physicians and 43% pharmacists (age average 31-40 years). 47% had correctly defined Pharmacovigilance while 19% know what is meant by adverse drug reactions. Moreover, 61% of the participants did not share information about raising adverse drug reactions in some patients with other healthcare professionals. 35% of them did not know about the adverse drug reactions reporting system in Libya. Whereas, 42% have strongly agreed that reporting adverse drug reactions is essential. 41% and 45% of participants believed that reporting adverse drug reactions is not time-consuming and increases patient safety, respectively. In conclusion, educational programs and training courses about the importance of Pharmacovigilance for physicians and pharmacists in Benghazi are needed.

Share :